‘Creating a Healthier Asia’ is Gilead’s awareness campaign highlighting pressing concerns ranging from misinformation, inaction, delayed diagnosis, and other barriers to receiving care, seen through the lens of people living with hepatitis B in Asia.
The WHO has set clear and targeted goals to eliminate viral hepatitis as a public health threat by 2030. At Gilead, we aim to partner with local communities to help work towards these goals. To support these efforts, we continually strive to learn more about gaps in knowledge, awareness and attitudes towards liver health and liver diseases.
One step to gaining this deeper understanding is the first Liver Index study, conducted by Gilead across 11 countries and territories in Asia in 2020.
The Index results found that increasing education and raising public awareness, coupled with adopting a multi-sectoral collaborative approach to addressing viral hepatitis, can help make the 2030 elimination goal possible.
# Lee, M.H., Ahn, S.H., Chan, H.L., Choudhry, A., Alvani Gani, R., Mohamed, R., Ong, J.P., Shukla, A., Tan, C.K., Tanwandee, T. and Thuy, P.T.T., 2022. Contextual and individual factors associated with knowledge, awareness and attitude on liver diseases: A large‐scale Asian study. Journal of Viral Hepatitis, 29(2), pp.156-170 .